USE OF BLUETONGUE VIRUS PROTEINS AS VACCINE COMPONENTS

摘要

2075945 9100741 PCTABS00003 A protective effect against bluetongue infection in susceptible mammals which is obtained by inoculating said mammals with a polypeptide comprising at least an antigenic portion of bluetongue virus structural protein VP2 in antigenic form produced by transforming a host with a recombinant expression vector having a DNA segment coding for said polypeptide.